ArticleCureus2021

Clinical Outcomes and Costs of Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Inpatients: A Cross-Sectional Study.

Gustavo Lenci Marques et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.